Viromed Medical AG (VME)
Market Closed
17 Jul, 15:30
XETRA XETRA Primary XDUS €
7. 95
+0.5
+6.7114%
€
147.82M Market Cap
- P/E Ratio
- Div Yield
5,002 Volume
- Eps
€ 7.45
Previous Close Want to track VME and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Viromed Medical AG (VME) Statistics
Valuation metrics
Market Cap 147.82M
Enterprise value 101.14M
Trailing P/E (ttm) -648.54
Forward P/E 15.58
PEG ratio 15.58
Price/Sales (ttm) -
Price/Book (mrq) -
Enterprise Value/Revenue -
Enterprise Value/EBITDA -475.84
Overview
Shares outstanding 20.25M
Float -
Shares short -
% Held by insiders -
% Held by institutions 0%
Average volume (10 days) 4.07K
Average volume (90 days) 7.71K
Price summary
52-Week low 2.6
52-Week high 8.45
Beta -
50-Day moving average 6.11
200-Day moving average 4.89
Financials
Fiscal year
Fiscal year ends 31 Dec 2024
Most recent quarter (mrq) 30 Jun 2025
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.01%
Return on equity -0.01%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -226.37K
Diluted EPS (ttm) -0.02
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 17.67K
Total cash per share (mrq) 0
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 0.3%
Book value per share (mrq) -
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -226.37K
